VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar stockfreak1 (< 20) Submitted: 9/21/2010 10:42:08 AM : Underperform Start Price: $6.99 VVUS Score: -236.07

dead horse

Featured Broker Partners


Advertisement